EWM
AQST icon

Edge Wealth Management’s Aquestive Therapeutics AQST Stock Holding History

Edge Wealth Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed -$1K – 631
2019
Q4 		$1K Hold
100
– – ﹤0.01% 549
2019
Q3 		$1K Hold
100
– – ﹤0.01% 547
2019
Q2 		$1K Hold
100
– – ﹤0.01% 550
2019
Q1 		$1K Buy
+100
New +$701 ﹤0.01% 532

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Edge Wealth Management's AQST Position: Q1 2020 in Review

Edge Wealth Management sold out of Aquestive Therapeutics (AQST) in Q1 2020, closing a stake of 100 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in AQST in Q1 2019 and held it in 4 quarters. The position peaked at $1K in Q4 2019. 42 funds tracked by Wall St. Rank hold AQST as of Q1 2020.

  • Edge Wealth Management reported no remaining Aquestive Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Edge Wealth Management sold 100 Aquestive Therapeutics shares in Q1 2020, an estimated $1K.
  • Edge Wealth Management first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 4 quarters.
  • Edge Wealth Management's Aquestive Therapeutics position peaked at $1K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2020.

Based on Edge Wealth Management's 13F filing for Q1 2020, filed 20 Apr 2020.